Thomas McCourt
Chief Executive Officer bij IRONWOOD PHARMACEUTICALS, INC.
Vermogen: 11 M $ op 31-03-2024
Profiel
Thomas A.
McCourt is the founder of Astra Merck, Inc., which was founded in 1992.
He held the title of Manager-Prilosec & Nexium Brand from 1992 to 1999.
Mr. McCourt's current job(s) include being the President, Chief Executive Officer & Director at Ironwood Pharmaceuticals, Inc. since 2009, an Independent Director at Pliant Therapeutics, Inc. since 2023, and a Trustee at the American Society for Gastrointestinal Endoscopy since 2009.
Mr. McCourt's former job(s) include being an Independent Director at Acceleron Pharma, Inc. from 2016 to 2021, and Vice President-Strategic Marketing & Operations at Novartis AG from 2001 to 2008.
Mr. McCourt's education history includes completing his undergraduate degree at the University of Wisconsin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-03-2024 | 1 217 948 ( 0.78% ) | 11 M $ | 31-03-2024 | |
| 07-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Thomas McCourt
| Bedrijven | Functie | Begin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12-03-2021 |
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 06-03-2023 |
| American Society for Gastrointestinal Endoscopy | Director/Board Member | 01-05-2009 |
Eerdere bekende functies van Thomas McCourt
| Bedrijven | Functie | Einde |
|---|---|---|
| ACCELERON PHARMA INC. | Director/Board Member | 19-11-2021 |
| NOVARTIS AG | Sales & Marketing | 01-01-2008 |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Founder | 01-06-1999 |
Opleiding van Thomas McCourt
| University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
| American Society for Gastrointestinal Endoscopy |
